The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 8 of the 14 sources its claims cite were checked for support.
Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair
Open accessAbstract
OBJECTIVE: To identify clinical and demographic characteristics associated with prolapse recurrence by 12 months after native tissue transvaginal repair. METHODS: This was a planned secondary analysis of a randomized trial including postmenopausal participants with stage 2 or greater apical or anterior vaginal prolapse scheduled for surgical repair at three U.S. sites. Participants underwent vaginal hysterectomy (if uterus was present) and standardized uterosacral or sacrospinous ligament suspension at the surgeon's discretion. The intervention was perioperative (5 weeks or more preoperatively and 12 months postoperatively) vaginal estrogen compared with placebo cream. The primary outcome was time to failure by 12 months after surgery, defined by objective prolapse of the anterior or posterior walls beyond the hymen or the apex descending more than one-third of the vaginal length, symptomatic vaginal bulge, or retreatment. For this analysis, participants were grouped according to failure compared with success, and multiple factors were compared, including age, time since menopause, race and ethnicity, parity, body mass index (BMI), baseline genital hiatus measurement, prolapse stage and point of maximal prolapse, surgery type (uterosacral or sacrospinous ligament suspension), and concomitant procedures. Factors were assessed for association with the hazard of surgical failure using Cox proportional hazards models, adjusted for site and treatment group. Factors with P <.50 from this analysis were considered for inclusion in the final multivariable model; site and treatment group were kept in this model. RESULTS: One hundred eighty-six participants underwent surgery; 183 provided complete data. There were 30 failures (16.4%) and 153 successes (83.4%) at 12 months. On bivariate analysis, failure was associated with decreasing age, shorter duration since menopause, Latina ethnicity, and greater baseline genital hiatus. In the final multivariable model, which included age, BMI, and point of maximal prolapse, only age remained significantly associated with surgical failure (adjusted hazard ratio [per year] 0.92, 95% CI, 0.86-0.98, P =.016). CONCLUSION: Among postmenopausal women, younger age was associated with increased frequency of prolapse recurrence by 12 months after native tissue repair. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov , NCT02431897.
Overview
CoChat Summary
TL;DR
In a planned secondary analysis of the IMPROVE randomized trial, 30 of 183 postmenopausal women (16.4%) met a composite definition of surgical failure by 12 months after native tissue transvaginal apical prolapse repair. In the final multivariable Cox model, only younger age remained significantly associated with failure (adjusted HR 0.92 per year, 95% CI 0.86–0.98; p=0.016).
Key findings
- By 12 months, there were 30/183 (16.4%) failures and 153/183 (83.4%) successes. The most common failure type was anatomic (n=16, 53.3%); 10 of these 16 were due to descent of the vaginal apex greater than one-third of total vaginal length and not prolapse of any compartment beyond the hymen. Nine (30.0%) failures were symptomatic only, 4 (13.3%) met both anatomic and symptomatic definitions, and 1 (3.3%) had retreatment.
- On bivariate analysis, failure was associated with decreasing age, shorter duration since menopause, and greater baseline genital hiatus measurement; those identifying as Latina ethnicity experienced increased recurrence. Race, number of prior vaginal deliveries, diabetes, prior hysterectomy, prior prolapse or incontinence surgery, BMI, baseline POP-Q stage, “POP-Q Max,” apical surgery type, and concomitant procedures were not associated with failure.
- In the final multivariable model including age, BMI, and baseline “POP-Q Max” (adjusted for site and treatment group), only age remained significant: adjusted HR 0.92 per year (95% CI 0.86–0.98), p=0.016. A 2-year increase in age had HR 0.85 (95% CI 0.74–0.97), corresponding to approximately 15% greater likelihood of recurrent prolapse with each 2-year reduction in age.
- In a post-hoc analysis using a revised anatomic failure definition, decreasing age and increasing genital hiatus remained significantly associated with increased surgical failure in bivariate analysis.
Methods
- Planned secondary analysis of the IMPROVE randomized superiority trial (NCT02431897). Participants were postmenopausal women (48 years or greater) with bothersome anterior or apical vaginal prolapse extending beyond the hymen who were planning elective surgical repair at 3 US sites, enrolled between December 2016 and February 2020. They were randomized 1:1 to perioperative vaginal estrogen cream versus placebo cream.
- Surgery consisted of vaginal hysterectomy if the uterus was present, followed by standardized uterosacral or sacrospinous ligament suspension at the surgeon’s discretion; concomitant anterior or posterior repair or midurethral sling was allowed, and no mesh placement for prolapse repair was permitted.
- The primary outcome was time-to-failure by 12 months, defined as objective prolapse of the anterior or posterior walls beyond the hymen or apex descending greater than one-third vaginal length, symptomatic vaginal bulge, or retreatment. Participants were grouped by failure versus success; factors were compared using t-test, Kruskal-Wallis test, and chi-square test, then assessed with Cox proportional hazards models adjusting for site and treatment group. Factors with p<0.50 in minimally adjusted analysis were considered for a final multivariable model restricted to 3 variables plus site and treatment group; analysis was performed in R 4.2.2.
Limitations
- Stated in the paper: follow-up was relatively short at 12 months; the anatomic definition of apical failure (apex descending greater than one-third total vaginal length) may be conservative, and there remains no universally accepted definition of prolapse recurrence; the analysis presumed “once a failure, always a failure,” although some participants may meet failure criteria at one visit and not later; no data were collected on levator avulsion, levator contractility, chronic constipation, or family history of prolapse; and results are limited to transvaginal native tissue repair and cannot necessarily be extrapolated to all routes of prolapse repair.
- Evident from the text: this was a secondary analysis with only 30 failures, so the final multivariable model was restricted to 3 variables plus site and treatment group, limiting power and adjustment. Some race/ethnicity subgroups were very small (e.g., Black race n=4 failures, Asian n=0, “none of the above” n=0), making those bivariate findings fragile.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 2 Not valid · 5 Not checked · 38 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“These have been shown to be essentially equivalent in efficacy.9”
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > METHODS
What the sources say
- Supportedcites [9] source
The Results (Surgical Intervention Outcomes; page unavailable) report similar two-year surgical success rates for uterosacral ligament suspension (59.2%) and sacrospinous ligament fixation (60.5%), with no statistically significant difference. This supports the claim of essentially equivalent efficacy in the outcomes studied. (LLM, conf=0.91)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This was a planned ancillary analysis of a randomized superiority trial (NCT02431897), the design of which and primary outcome report have been previously published.7,8”
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > METHODS
What the sources say
- Partly supportedcites [7] sourceExperimental — accuracy not yet measured
The Methods identify IMPROVE as NCT02431897, and the Primary Outcome Measure section describes a randomized trial designed to test superiority over placebo. This design paper does not establish that the citing study was a planned ancillary analysis; it also does not report the trial’s primary outcome. (LLM, conf=0.86)
- Supportedcites [8] source
The Methods (Study Design; page unavailable) identify this as a randomized superiority trial and say its design was published previously. The trial-registration passage identifies NCT02431897, and the Results (Primary Outcome; page unavailable) report the primary outcome. Whether the citing authors’ own analysis was planned and ancillary is not attributed to this source. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The application of estrogen cream did not improve recurrence rates; the adjusted hazard ratio of failure for vaginal estrogen compared with placebo was 1.97 (95% CI, 0.92-4.22;P = 0.08).”
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > METHODS
What the sources say
- Supportedcites [8] source
The Results (Primary Outcome) report no statistically significant difference in failure risk between vaginal estrogen and placebo, with an adjusted hazard ratio of 1.97 (95% CI, 0.92–4.22; P = .08). The Discussion likewise states that perioperative vaginal estrogen cream did not improve surgical outcomes at 12 months after native tissue apical prolapse repair. (LLM, conf=0.95)
plainn = 20- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Race was not associated with failure, but, in this cohort, those identifying as Latina ethnicity experienced increased recurrence.”
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“4 (13.3%)met both anatomic and symptomatic failure definitions;”
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
21 more claims
Create a free account to see all 49 claims and every source verdict.
- It may state two separate claims as one. 8
- Probably not a substantial claim. 18
- The quote only partly states this claim. 3
- Borderline: one of the tests for a substantial claim is unclear. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Identified anatomical factors reported to be associated with a greater likelihood of prolapse recurrence include the presence or absence of levator ani muscle avulsion from the pubis, a larger rather than smaller levator hiatus, and a greater pre‐operative prolapse stage [14].”
From How Can We Improve the Assessment and Indifferent Outcomes From Pelvic Organ Prolapse Management From Conservative and Surgical Therapies? ICI‐RS 2025 (2026) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 65 to <70 | 35 | 8 | 22.3 |”
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > DISCUSSION
Reported 22.3 · recomputed 22.857143
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > DISCUSSION
“| Concomitant midurethral sling, n (%) | 183 | 14 (70.0) | 89 (54.6) | 0.19 |”
§ Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair > DISCUSSION
“Concomitant midurethral sling, n (%) 183 10 (33.3) 83 (54.2) 0.21”
Citations
Cites
The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction
Bump, R. C., Mattiasson, A., Bø, K., Brubaker, L. P., DeLancey, J. O. L., Klarskov, P., Shull, B. L., & Smith, A. R. B. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70243-0 · Cited by 4,275
Barber, M. D., Walters, M. D., & Bump, R. C. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.025 · Cited by 1,357
Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery
Wu, J. M., Matthews, C. A., Conover, M. M., Pate, V., & Jonsson Funk, M. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000286 · Cited by 1,111
Lifetime Risk of Undergoing Surgery for Pelvic Organ Prolapse
Smith, F. J., Holman, C. D. J., Moorin, R. E., & Tsokos, N. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181f73729 · Cited by 822
Applied Regression Analysis and Other Multivariate Methods
Sharma, S., Kleinbaum, D. G., & Kupper, L. L. (1978) · Journal of Marketing Research · doi:10.2307/3150614 · Cited by 785 · cited 1×
“17,18 The proportional hazards assumption was tested with the Grambsch – Therneau test, and the fit of the model was assessed with residual plots.”
MethodLong-term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse
Nygaard, I., Brubaker, L., Zyczynski, H. M., Cundiff, G., Richter, H., Gantz, M., Fine, P., Menefee, S., Ridgeway, B., Visco, A., et al. (2013) · JAMA · doi:10.1001/jama.2013.4919 · Cited by 563
Self-citationBarber, M. D., Brubaker, L., Burgio, K. L., Richter, H. E., Nygaard, I., Weidner, A. C., Menefee, S. A., Lukacz, E. S., Norton, P., Schaffer, J., et al. (2014) · JAMA · doi:10.1001/jama.2014.1719 · Cited by 428
Self-citationShull, B. L., Bachofen, C., Coates, K. W., & Kuehl, T. J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.110910 · Cited by 415
Surgery for women with apical vaginal prolapse
Maher, C., Feiner, B., Baessler, K., Christmann-Schmid, C., Haya, N., & Brown, J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012376 · Cited by 390
Risk factors for prolapse recurrence after vaginal repair
Whiteside, J. L., Weber, A. M., Meyn, L. A., & Walters, M. D. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.109 · Cited by 329
Cited by
Rahn, D. D., Richter, H. E., Sung, V. W., & Pruszynski, J. E. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.04.042 · Cited by 9
Self-citationWESTON, K., Kenne, K. A., Bradley, C. S., Wendt, L. H., & Kowalski, J. T. (2026) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2026.04.012 · Cited by 2
Kearney, R., Wagg, A., Bower, W., Chapple, C., Khullar, V., Robinson, D., Taithongchai, A., Hobson, P. T., Wein, A., & Abrams, P. (2026) · Neurourology and Urodynamics · doi:10.1002/nau.70272 · Cited by 1
Deszensuskorrektur ohne Fremdmaterial: Jüngere Frauen erleiden häufiger Rezidive
Lorenz, J. (2024) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-2272-4233
The Impact of Genital Hiatus in the Long-term Outcomes of Apical Prolapse Repair
Kofman, R., & Khan, A. A. (2025) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-025-00795-5
“For example, both Rahn et al. and Schmidt et al. used preoperative GH size to assess recurrence rates [11, 12].”
Influential
Metadata
- Authors
- Rahn, D. D., Richter, H. E., Sung, V. W., Hynan, L. S., & Pruszynski, J. E.
- Affiliations
- University of Alabama at Birmingham (US)
- Venue
- Obstetrics & Gynecology
- Published
- 2023-12-07
- Volume
- 143
- Issue
- 2
- Pages
- 312-319
- ISSN
- 0029-7844 (ISSN-L)
- 1873-233X
- PMC
- PMC10841579
- OpenAlex
- W4389427023
- Cited by
- 7
- References
- 27
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 2
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01 AG047290)
- American College of Obstetricians and Gynecologists (Bridge Award)
- Pfizer (Investigator initiated award, WI195371)
- National Center for Advancing Translational Sciences (UL1 TR003163)
- Topics
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- apical vaginal prolapse, native tissue repair, prolapse recurrence, surgical failure, postmenopausal women, uterosacral ligament suspension, sacrospinous ligament suspension, vaginal estrogen, age as risk factor, genital hiatus, body mass index
- MeSH terms
- Female, Humans, Hysterectomy, Vaginal, Infant, Gynecologic Surgical Procedures, Uterine Prolapse, Uterus, Vagina, Treatment Outcome, Pelvic Organ Prolapse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair. https://app.cochat.ai/papers/10.1097/aog.0000000000005478
- The paper
- Rahn, D. D., Richter, H. E., Sung, V. W., Hynan, L. S., & Pruszynski, J. E. (2024). Characteristics Associated With Surgical Failure After Native Tissue Apical Prolapse Repair. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000005478
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.